Novavax (NVAX) Shares Outstanding (2010 - 2026)

Novavax's Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $100.8 million for Q4 2023.

• On a quarterly basis, Shares Outstanding (Entity) rose 16.08% year-over-year to $100.8 million in Q4 2023; TTM through Dec 2023 was $100.8 million, a 16.08% increase from a year earlier, with the FY2023 full-year figure at $100.8 million, up 16.08% from the prior year.
• Shares Outstanding (Entity) fell to $100.8 million in Q4 2023 per NVAX's latest filing, from $119.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $119.6 million in Q3 2023 and bottomed at $23.5 million in Q1 2019.
• The 5-year median for Shares Outstanding (Entity) is $75.3 million (2021), against an average of $67.6 million.
• Across the five-year window, Shares Outstanding (Entity) jumped 139347.24% in 2019 and grew 4.25% in 2022, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $24.1 million in 2019, then soared by 138.81% to $57.6 million in 2020, then soared by 32.8% to $76.4 million in 2021, then rose by 13.57% to $86.8 million in 2022, then rose by 16.08% to $100.8 million in 2023.
• Per Business Quant, the three latest NVAX Shares Outstanding (Entity) figures stand at $100.8 million (Q4 2023), $119.6 million (Q3 2023), and $95.2 million (Q2 2023).